+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Genetically Modified Foods - Global Strategic Business Report

  • PDF Icon

    Report

  • 186 Pages
  • October 2026
  • Region: Global
  • Market Glass, Inc.
  • ID: 6094889
The global market for Genetically Modified Foods was valued at US$119.8 Billion in 2025 and is projected to reach US$182.4 Billion by 2032, growing at a CAGR of 6.2% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global 'Genetically Modified Foods' Market - Key Trends & Drivers Summarized

Why Are Genetically Modified Foods Gaining Global Traction Despite Ongoing Controversies?

The global market for genetically modified (GM) foods is undergoing a significant expansion, driven by growing demand for sustainable agriculture, food security, and nutritional innovation. GM foods are created through precise genetic engineering techniques, where specific traits such as drought resistance, pest tolerance, or enhanced nutrition are introduced into the DNA of crops. These advancements offer promising solutions to critical challenges including climate change, declining arable land, and the need to feed a rising global population. Despite enduring public skepticism, especially in parts of Europe and Asia, the adoption of GM crops is accelerating in regions like North America, South America, and Africa due to their yield-boosting and cost-reducing capabilities. Crops like genetically modified soybeans, maize, cotton, and canola dominate agricultural landscapes in countries such as the United States, Brazil, and Argentina. Beyond commodity crops, GM technology is now being applied to develop enhanced varieties of fruits, vegetables, and staple foods such as golden rice, which is engineered to combat vitamin A deficiency. This evolving science is not only reshaping food production but also influencing global trade dynamics and regulatory frameworks. While debates around labeling, biosafety, and environmental ethics persist, the market’s forward momentum continues as more governments and consumers recognize the role of biotechnology in meeting the world’s nutritional needs under increasingly challenging conditions.

How Are Innovations in Genetic Engineering Reshaping the GM Foods Landscape?

The technological foundation of genetically modified foods is rapidly evolving, with a new wave of precision breeding tools pushing the boundaries of what genetic engineering can achieve. CRISPR-Cas9 and other gene-editing techniques now allow scientists to make targeted changes at the DNA level without introducing foreign genes, making gene-edited foods more acceptable in certain regulatory environments. These tools have given rise to what some term the “next-gen GMOs,” which include crops with enhanced climate resilience, improved photosynthetic efficiency, and optimized nutrient content. Companies are also focusing on reducing allergenicity and producing plant-based foods with higher shelf stability, better texture, and greater nutritional density. For example, gene-edited mushrooms that resist browning and non-browning apples have already reached the commercial market. Additionally, synthetic biology is enabling the creation of entirely novel food ingredients such as lab-grown dairy proteins and meat substitutes that are not derived from traditional livestock or crops. These products are transforming consumer perceptions of GM foods by focusing on health and environmental benefits. Further integration with AI and data analytics is allowing for faster identification of desirable traits and shorter development cycles. At the same time, open-source biotechnology platforms are democratizing access to these tools, encouraging participation from smaller agricultural producers and research institutions. These ongoing innovations are turning genetic modification into a multi-functional solution that extends well beyond conventional pest or herbicide resistance, supporting the broader goals of food innovation and sustainability.

How Are Consumers, Retailers, and Governments Responding to the GM Foods Revolution?

Consumer response to genetically modified foods remains complex and highly variable across global regions, with attitudes shaped by cultural values, economic priorities, and information access. In North America, particularly the United States and Canada, GM foods are widely accepted and commonly found in supermarkets, with minimal consumer resistance. Conversely, in the European Union, strict regulatory policies and consumer wariness have slowed market penetration, prompting many food producers to pursue “non-GMO” labeling to meet demand. Meanwhile, in developing countries facing food shortages and agricultural instability, GM crops are increasingly seen as tools for food security and economic growth. Public perception is gradually evolving, especially as new genetically modified products focus on nutrition and sustainability rather than corporate farming benefits. Retailers and food manufacturers are adapting by offering both GMO and non-GMO lines to appeal to diverse consumer segments. Some are partnering with biotech firms to co-develop transparent labeling systems and traceability solutions, enhancing trust in GM food supply chains. Governments are also playing a decisive role through policy frameworks that govern GM crop approval, cultivation, and import/export. Regulatory agencies in nations like Brazil, the U.S., and India are streamlining their biotech approval processes, while others like China are beginning to ease long-standing restrictions. International organizations such as the FAO and WHO have issued guidelines supporting the safe use of GM technology to address malnutrition and hunger. These shifts in stakeholder attitudes are contributing to a more nuanced and pragmatic global dialogue around the role of genetically modified foods in modern agriculture.

What’s Powering the Growth of the Global Genetically Modified Foods Market?

The growth in the genetically modified foods market is driven by several factors directly linked to technological advancements, shifting agricultural needs, consumer behavior, and policy evolution. One of the primary drivers is the increasing pressure on global food systems to become more efficient, resilient, and productive in the face of climate variability, soil degradation, and water scarcity. Genetically modified crops are being adopted for their ability to produce higher yields under stress conditions such as drought, high salinity, and pest infestation - factors that are particularly pressing in developing agricultural economies. The rising demand for biofortified foods, which offer enhanced nutritional content, is another key contributor, especially in regions grappling with micronutrient deficiencies. On the technological front, innovations in gene-editing and synthetic biology are enabling faster, cheaper development of customized crop varieties with regulatory pathways that differ from older GMO techniques, expanding market access. There is also strong industry support from agrochemical and seed companies investing in next-gen GM technologies to retain competitive advantage. Increasing public-private partnerships in agricultural biotechnology are helping scale these innovations, particularly in Africa and Asia. Meanwhile, consumer demand for sustainable, long-lasting, and health-focused food products is aligning with GM innovations that promise lower spoilage, reduced food waste, and enriched nutritional profiles. Lastly, supportive regulatory shifts in key markets such as China, India, and the Philippines - where food security is a national priority - are opening doors for commercial cultivation and cross-border trade in GM food commodities. All these drivers collectively point to a robust and expanding global market for genetically modified foods, increasingly viewed not just as a scientific advancement but as a strategic necessity in modern food systems.

Report Scope

The report analyzes the Genetically Modified Foods market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:
  • Segments: Type (Genetically Modified Vegetables, Genetically Modified Crops, Genetically Modified Fruits, Genetically Modified Animal Products)
  • Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Genetically Modified Vegetables segment, which is expected to reach US$78.1 Billion by 2032 with a CAGR of a 5.0%. The Genetically Modified Crops segment is also set to grow at 7.9% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $32.6 Billion in 2025, and China, forecasted to grow at an impressive 9.2% CAGR to reach $37.4 Billion by 2032. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Genetically Modified Foods Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Genetically Modified Foods Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Genetically Modified Foods Market expected to evolve by 2032?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2032?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2025 to 2032.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as Aglukon Spezialchemie GmbH, BASF SE, Bayer CropScience, Benson Hill, Bioceres S.A. and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the companies featured in this Genetically Modified Foods market report include:

  • Aglukon Spezialchemie GmbH
  • BASF SE
  • Bayer CropScience
  • Benson Hill
  • Bioceres S.A.
  • Cargill Inc.
  • Corteva Agriscience
  • Dow AgroSciences (Corteva)
  • DuPont Pioneer
  • E.I. du Pont de Nemours and Co.
  • East West Seed Co.
  • FMC Corporation
  • Germains Seed Technology
  • GMO Answers (BioIndustry)
  • Greenhouse Seed Co.
  • Huxley and Partners Ltd.
  • International Food Policy Research Institute (IFPRI)
  • KWS SAAT SE & Co. KGaA
  • Limagrain
  • Monsanto (now part of Bayer)

What Sets This Report Apart From Others?

  • Grounded in Domain Expert Perspectives: Incorporates perspectives emerging from domain experts across industry, enterprise and academia, adding context beyond conventional published research.
  • Captures Early Market Signals: Tracks shifts emerging through expert conversations, company activity and market-relevant discussions before they are fully reflected in traditional secondary research.
  • Draws From a Broad, Validated Intelligence Base: Brings together insights from conference sessions, keynotes, panel discussions, blogs, corporate disclosures, annual reports, institutional publications and other validated sources.
  • Connects Signals With Strategic Market Direction: Synthesizes these perspectives to identify where the market is moving, what is driving that movement and which developments are likely to matter most for strategy.
  • Provides In-Depth Company Intelligence: Extends beyond market-level analysis to examine the companies participating in and shaping the competitive environment.
  • Market Share Is Examined Where It Matters: A single global market share figure rarely tells the full story. Competitive structures can vary significantly across geographies. Where analytically relevant, the report extends market share analysis into major regions with the level of detail tailored to the structure and dynamics of each market.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
  • World Market Trajectories
  • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
  • Genital Warts Treatment - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • High Prevalence of HPV Infections Throws the Spotlight on Genital Warts Treatment Options
  • Growing Awareness of Sexual Health Propels Demand for Prescription and OTC Wart Therapies
  • Push for Early Diagnosis and STI Screening Expands Addressable Market for Topical Treatments
  • Increased HPV Vaccination Rates Influence Market Shifts in Prophylactic and Therapeutic Approaches
  • Focus on Cryotherapy and Immunomodulators Strengthens Product Innovation in Clinical Settings
  • Rising Preference for Non-Invasive, At-Home Treatment Kits Supports Growth in Patient-Directed Therapies
  • Digital Health Platforms and Teledermatology Accelerate Access to Genital Wart Consultations
  • Integration of Wart Treatments into Sexual Health Clinics Drives Volume in Reproductive Health Markets
  • Push for Evidence-Based Therapy Adoption Promotes Use of FDA-Approved Podophyllotoxin and Imiquimod
  • Stigma Reduction and Public Education Campaigns Encourage Uptake of Preventive and Treatment Services
  • HPV Strain Evolution and Resistance Challenges Spur Pipeline Development of Broader-Spectrum Solutions
  • Advances in Molecular Diagnostics Support Personalized Treatment and Co-Infection Management
  • Increasing Incidence Among Immunocompromised Populations Sustains Demand for Long-Term Treatment
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Genital Warts Treatment Market Analysis of Annual Sales in US$ Thousand for Years 2020 through 2032
  • Table 2: World Recent Past, Current & Future Analysis for Genital Warts Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 3: World Historic Review for Genital Warts Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 4: World 13-Year Perspective for Genital Warts Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2020, 2026 & 2032
  • Table 5: World Recent Past, Current & Future Analysis for Imiquimod by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 6: World Historic Review for Imiquimod by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 7: World 13-Year Perspective for Imiquimod by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 8: World Recent Past, Current & Future Analysis for Podophyllin & Podofilox by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 9: World Historic Review for Podophyllin & Podofilox by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 10: World 13-Year Perspective for Podophyllin & Podofilox by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 11: World Recent Past, Current & Future Analysis for Trichloroacetic Acid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 12: World Historic Review for Trichloroacetic Acid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 13: World 13-Year Perspective for Trichloroacetic Acid by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 14: World Recent Past, Current & Future Analysis for Sinecatechins by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 15: World Historic Review for Sinecatechins by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 16: World 13-Year Perspective for Sinecatechins by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 17: World Recent Past, Current & Future Analysis for Other Drug Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 18: World Historic Review for Other Drug Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 19: World 13-Year Perspective for Other Drug Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 20: World Recent Past, Current & Future Analysis for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 21: World Historic Review for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 22: World 13-Year Perspective for Online Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 23: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 24: World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 25: World 13-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 26: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 27: World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 28: World 13-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 29: World Recent Past, Current & Future Analysis for Parenteral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 30: World Historic Review for Parenteral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 31: World 13-Year Perspective for Parenteral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 32: World Recent Past, Current & Future Analysis for Topical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 33: World Historic Review for Topical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 34: World 13-Year Perspective for Topical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
III. MARKET ANALYSIS
UNITED STATES
  • Genital Warts Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
CANADA
JAPAN
  • Genital Warts Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
CHINA
  • Genital Warts Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
EUROPE
  • Genital Warts Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
FRANCE
  • Genital Warts Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
GERMANY
  • Genital Warts Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
ITALY
UNITED KINGDOM
  • Genital Warts Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
SPAINRUSSIAREST OF EUROPE
ASIA-PACIFIC
  • Genital Warts Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2026 (E)
AUSTRALIA
  • Genital Warts Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2026 (E)
INDIA
  • Genital Warts Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2026 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Genital Warts Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2026 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Genital Warts Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2026 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Genital Warts Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2026 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Aglukon Spezialchemie GmbH
  • BASF SE
  • Bayer CropScience
  • Benson Hill
  • Bioceres S.A.
  • Cargill Inc.
  • Corteva Agriscience
  • Dow AgroSciences (Corteva)
  • DuPont Pioneer
  • E.I. du Pont de Nemours and Co.
  • East West Seed Co.
  • FMC Corporation
  • Germains Seed Technology
  • GMO Answers (BioIndustry)
  • Greenhouse Seed Co.
  • Huxley and Partners Ltd.
  • International Food Policy Research Institute (IFPRI)
  • KWS SAAT SE & Co. KGaA
  • Limagrain
  • Monsanto (now part of Bayer)

Table Information